Offer - Urjas Oil for just ₹ 1
Corbis H 2.5 Tablet is a commercial drug that is prescribed in the form of Tablet. Secondary and off-label uses of Corbis H 2.5 Tablet have also been mentioned below.
The optimal dosage of Corbis H 2.5 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Corbis H 2.5 Tablet as well, which are listed below. Such side effects of Corbis H 2.5 Tablet normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Corbis H 2.5 Tablet has a Safe effect for pregnant women and Safe effect on lactating mothers. Further, the section on Corbis H 2.5 Tablet related warnings talks about Corbis H 2.5 Tablet's effects on the liver, heart and kidney.
Corbis H 2.5 Tablet is contraindicated in people with pre-existing medical conditions like Diabetes, Asthma, Liver Disease as it can result in adverse effects. Other conditions have been mentioned below in the Corbis H 2.5 Tablet contraindications section.
Drug reaction of Corbis H 2.5 Tablet with other medicines has been reported. A complete list of these interactions is given below.
In addition to the above precautions for Corbis H 2.5 Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Corbis H 2.5 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Is the use of Corbis H 2.5 Tablet safe for pregnant women?
Pregnant women can take Corbis H safely.
Is the use of Corbis H 2.5 Tablet safe during breastfeeding?
Corbis H is completely safe for breastfeeding women.
What is the effect of Corbis H 2.5 Tablet on the Kidneys?
Corbis H rarely affects the kidneys.
What is the effect of Corbis H 2.5 Tablet on the Liver?
Corbis H may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Corbis H 2.5 Tablet on the Heart?
Very few cases of side effects of Corbis H on the heart have been reported.
If you are suffering from any of the following diseases, you should not take Corbis H 2.5 Tablet unless your doctor advises you to do so -
Is this Corbis H 2.5 Tablet habit forming or addictive?
No, there is no any evidence that Corbis H 2.5 Tablet is addictive.
Interaction between Food and Corbis H 2.5 Tablet
Eating certain foods may increase the time it takes Corbis H 2.5 Tablet to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Corbis H 2.5 Tablet
Consult your doctor before consuming alcohol while taking Corbis H 2.5 Tablet as it can have severe side effects.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 229
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 149
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Bisoprolol An (bisoprolol fumarate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Bisoprolol Sandoz® (bisoprolol fumarate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hydrochlorothiazide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 582-586
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448
